Receptor reserve and affinity of mu opioid agonists in mouse antinociception: correlation with receptor binding
- PMID: 7475964
- DOI: 10.1016/0024-3205(95)02204-v
Receptor reserve and affinity of mu opioid agonists in mouse antinociception: correlation with receptor binding
Abstract
In order to quantitate the extent to which opioid agonist potencies obtained in behavioral assays are determined by the apparent in vivo affinity and efficacy of the agonist, the antinociceptive effects of the mu opioid agonists morphine, fentanyl, etonitazene, and NIH 10741 were assessed before and after administration of the insurmountable mu opioid antagonist clocinnamox (CCAM) in a 55 degrees C warm-water tail withdrawal test in Swiss albino mice. Under control conditions, all four mu opioid agonists produced a full antinociceptive response with the following ED50 values (in mg/kg): morphine, 12; fentanyl, 0.47; etonitazene, 0.039; NIH 10741, 0.0051. Analysis of CCAM's effects according to Black and Leff gave the following agonist efficacy or tau values: Morphine, 4; fentanyl 15, etonitazene, 7; and NIH 10741, 59. The respective KA values were (in mg/kg): morphine, 29; fentanyl, 7.3; etonitazene, 0.22; and NIH 10741, 0.30. The major determinant of the experimentally observed ED50 values seemed to be the apparent in vivo affinity of the respective agonist and not its efficacy. KA values (expressed as mol/kg) correlated with the Ki values (in mol/l) obtained with [3H]DAMGO radioligand binding (r = 0.96 for pKA vs. pKi), although being on average 11,000-fold higher. Values for q, the available receptor fraction as determined in the behavioral experiments, correlated strongly (r = 0.96) with the q values determined by ex vivo [3H]DAMGO- and [3H]naltrexone equilibrium binding (i.e., Bmax,clocinnamox/Bmax,control), the relationship approaching unity.
Similar articles
-
Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.J Pharmacol Exp Ther. 1996 Oct;279(1):23-31. J Pharmacol Exp Ther. 1996. PMID: 8858971
-
Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.J Pharmacol Exp Ther. 1994 Nov;271(2):715-21. J Pharmacol Exp Ther. 1994. PMID: 7965787
-
Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats.Eur J Pharmacol. 1997 Oct 15;337(1):27-34. doi: 10.1016/s0014-2999(97)01296-x. Eur J Pharmacol. 1997. PMID: 9389377
-
In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.J Pharmacol Exp Ther. 1994 Apr;269(1):57-65. J Pharmacol Exp Ther. 1994. PMID: 8169852
-
Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.J Pharmacol Exp Ther. 2000 Sep;294(3):933-40. J Pharmacol Exp Ther. 2000. PMID: 10945843
Cited by
-
Monoclonal Antibodies for Combating Synthetic Opioid Intoxication.J Am Chem Soc. 2019 Jul 3;141(26):10489-10503. doi: 10.1021/jacs.9b04872. Epub 2019 Jun 25. J Am Chem Soc. 2019. PMID: 31187995 Free PMC article.
-
The analgesic efficacy of fentanyl: relationship to tolerance and mu-opioid receptor regulation.Pharmacol Biochem Behav. 2008 Nov;91(1):115-20. doi: 10.1016/j.pbb.2008.06.019. Epub 2008 Jun 30. Pharmacol Biochem Behav. 2008. PMID: 18640146 Free PMC article.
-
In vivo apparent pA2 analysis in rats treated with either clocinnamox or morphine.Psychopharmacology (Berl). 1996 May;125(2):113-9. doi: 10.1007/BF02249409. Psychopharmacology (Berl). 1996. PMID: 8783384
-
Effects of μ-opioid receptor modulation on the hippocampal network activity of sharp wave and ripples.Br J Pharmacol. 2013 Mar;168(5):1146-64. doi: 10.1111/j.1476-5381.2012.02240.x. Br J Pharmacol. 2013. PMID: 23043226 Free PMC article.
-
Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.Eur J Pharmacol. 2007 Jun 1;563(1-3):92-101. doi: 10.1016/j.ejphar.2007.01.059. Epub 2007 Feb 8. Eur J Pharmacol. 2007. PMID: 17349996 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials